eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | autosomal dominant polycystic kidney disease |
| Comorbidity | C0022679|cystic kidney |
| Sentences | 3 |
| PubMedID- 24707279 | A large clinical study evaluating the effects of lanreotide on kidney volume and gfr in adpkd patients with polycystic kidney disease is now ongoing in the netherlands. |
| PubMedID- 25408801 | Introduction: we present our technique of laparoscopic nephrectomy for massive polycystic kidneys in patients with autosomal dominant polycystic kidney disease (adpkd) and review the outcome analysis of our experience. |
| PubMedID- 24058776 | In other words, everolimus was able to retard the growth of cystic kidneys in patients with adpkd but was not significantly able to slow the decline in renal function, while it was also associated with a high rate of side effects, similar to those observed in patients who were administered everolimus after undergoing kidney transplantation. |
Page: 1